chr18-3084010-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003803.4(MYOM1):c.4357A>T(p.Met1453Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00022 in 1,585,214 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003803.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYOM1 | NM_003803.4 | c.4357A>T | p.Met1453Leu | missense_variant | 32/38 | ENST00000356443.9 | NP_003794.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYOM1 | ENST00000356443.9 | c.4357A>T | p.Met1453Leu | missense_variant | 32/38 | 1 | NM_003803.4 | ENSP00000348821.4 | ||
MYOM1 | ENST00000261606.11 | c.4069A>T | p.Met1357Leu | missense_variant | 31/37 | 1 | ENSP00000261606.7 | |||
MYOM1 | ENST00000581075.1 | n.*3A>T | non_coding_transcript_exon_variant | 5/8 | 5 | ENSP00000462039.1 | ||||
MYOM1 | ENST00000581075.1 | n.*3A>T | 3_prime_UTR_variant | 5/8 | 5 | ENSP00000462039.1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152148Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000102 AC: 21AN: 205456Hom.: 0 AF XY: 0.000119 AC XY: 13AN XY: 109640
GnomAD4 exome AF: 0.000230 AC: 330AN: 1432948Hom.: 0 Cov.: 31 AF XY: 0.000209 AC XY: 148AN XY: 709640
GnomAD4 genome AF: 0.000125 AC: 19AN: 152266Hom.: 0 Cov.: 30 AF XY: 0.000134 AC XY: 10AN XY: 74454
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 13, 2024 | The c.4357A>T (p.M1453L) alteration is located in exon 32 (coding exon 31) of the MYOM1 gene. This alteration results from a A to T substitution at nucleotide position 4357, causing the methionine (M) at amino acid position 1453 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 29, 2016 | Variant classified as Uncertain Significance - Favor Benign. The p.Met1453Leu va riant in MYOM1 has not been previously reported in individuals with cardiomyopat hy, but has been identified in 5/19248 European chromosomes by the Exome Aggrega tion Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs181642354). Methi onine (Met) at position 1453 is not conserved in mammals or evolutionarily dista nt species, raising the possibility that a change at this position may be tolera ted. In summary, while the clinical significance of the p.Met1453Leu variant is uncertain, these data suggest that it is more likely to be benign. - |
Hypertrophic cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 05, 2024 | This sequence change replaces methionine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 1453 of the MYOM1 protein (p.Met1453Leu). This variant is present in population databases (rs181642354, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with MYOM1-related conditions. ClinVar contains an entry for this variant (Variation ID: 229026). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MYOM1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at